IHC analysis revealed that 15 samples of normal tissues and 7 low-grade gliomas (WHO II) did not express ALDH1A3 and that 37 of 38 GBM cases expressed ALDH1A3.114. The gene discussed is ALDH1A3; the disease is central nervous system cancer.